Skip to main content

Metoprolol (International)

In the US, Metoprolol (metoprolol systemic) is a member of the drug class cardioselective beta blockers and is used to treat Angina, Angina Pectoris Prophylaxis, Aortic Aneurysm, Atrial Fibrillation, Benign Essential Tremor, Heart Attack, Heart Failure, High Blood Pressure, Left Ventricular Dysfunction, Migraine Prevention, Mitral Valve Prolapse, Premature Ventricular Depolarizations, Supraventricular Tachycardia and Tapering Regimen.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C07AB02

CAS registry number (Chemical Abstracts Service)

0037350-58-6

Chemical Formula

C15-H25-N-O3

Molecular Weight

267

Therapeutic Categories

Antiarrhythmic agent, class II

Antihypertensive agent

β-adrenoceptor antagonist (beta blocker), cardioselective

Treatment of coronary heart disease

Treatment of heart failure (adjunct)

Chemical Name

2-Propanol, 1-[4-(2-metoxyetyl)phenoxy]-3-[(1-metyletyl)amino]-, (±)-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs